BioSpace News Archive

Biotech Beach

Janssen R&D’s INVOKANA (canagliflozin) Demonstrates Cardiovascular (CV) Risk Reductions in Type 2 Diabetes Patients With and Without a History of Prior CV Events

INVOKANA also achieved similar and proportional risk reductions for hospitalization due to heart failure and renal outcomes in each of the primary and secondary prevention groups.

November 14, 2017

·

15 min read

Drug Development

Data at SABCS and ASH Demonstrate Daiichi Sankyo Commitment to Advancing Science in Breast and Blood Cancer

Updated data from the ongoing phase 1 study of DS-8201, an investigational HER2-targeting ADC, in HER2-positive metastatic breast cancer as well as patients with HER2 low-expressing breast cancer will be highlighted as a Spotlight Poster Discussion at SABCS.

November 14, 2017

·

8 min read

Biotech Bay

Omnicell Supports Global Charity Mercy Ships by Donating Next Generation XT Series Equipment and Funds

Omnicell today announced it has donated equipment from the recently released XT series, resources to install and test the equipment, and additional funds to the global charity Mercy Ships.

November 14, 2017

·

4 min read

Business

Mustang Bio Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

As of September 30, 2017, Mustang’s cash and short-term investments (certificates of deposit) totaled $67.3 million, compared to $27.5 million at December 31, 2016, an increase of $39.8 million year-to-date.

November 14, 2017

·

9 min read

Stryker Nabs FDA OK for Cementless Mako Total Knee

FDA

Otsuka and Proteus Win First FDA Approval for Pill With Sensor to Track Ingestion

The embedded sensor will help keep track of whether patients are adhering to their prescriptions.

November 14, 2017

·

18 min read

Drug Development

EMA Grants Orphan Drug Designation to Debiopharm International’s FGFR Inhibitor Debio 1347 in the Treatment of Biliary Tract Cancer

Debio 1347 is an orally available small molecule selectively targeting FGFR 1, 2, 3 signaling pathways and is currently tested in a phase I study in patients with FGFR genomically activated advanced solid tumors.

November 14, 2017

·

2 min read

Drug Development

Achieve Life Science Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects

Study results demonstrated bioequivalence when cytisine was administered with or without food.

November 14, 2017

·

5 min read

Pharm Country

Merck Announces Final Results of Any and All Tender Offers

On Nov. 6, 2017, Merck commenced the Offers in accordance with the terms and conditions set forth in the Offer to Purchase, dated Nov. 6, 2017.

November 14, 2017

·

6 min read

Business

ITUS Corporation Licenses CAR-T Technology From the Wistar Institute

ITUS has formed a subsidiary, Certainty Therapeutics, to develop and commercialize the innovative CAR-T technology.

November 14, 2017

·

5 min read

Biotech Beach

Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure

Dr. Sanjiv Shah from Northwestern Memorial Hospital’s Center for Heart Failure at the Bluhm Cardiovascular Institute in Chicago will be presenting on behalf of the investigators, at the Innovative Therapies and Novel Applications session of the Late-Breaking Science program.

November 14, 2017

·

4 min read